Muutke küpsiste eelistusi

Handbook of Systemic Drug Treatment in Dermatology 3rd edition [Pehme köide]

Edited by (University of California, USA.), Edited by , Edited by (St. Mary's Hospital, London, UK)
  • Formaat: Paperback / softback, 288 pages, kõrgus x laius: 254x178 mm, kaal: 480 g, 29 Tables, black and white; 15 Line drawings, color; 3 Line drawings, black and white; 15 Illustrations, color; 3 Illustrations, black and white
  • Ilmumisaeg: 13-Feb-2023
  • Kirjastus: CRC Press
  • ISBN-10: 0367860813
  • ISBN-13: 9780367860813
Teised raamatud teemal:
  • Formaat: Paperback / softback, 288 pages, kõrgus x laius: 254x178 mm, kaal: 480 g, 29 Tables, black and white; 15 Line drawings, color; 3 Line drawings, black and white; 15 Illustrations, color; 3 Illustrations, black and white
  • Ilmumisaeg: 13-Feb-2023
  • Kirjastus: CRC Press
  • ISBN-10: 0367860813
  • ISBN-13: 9780367860813
Teised raamatud teemal:
"The Handbook of Systemic Drug Treatment in Dermatology helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. Written for dermatologists, family practitioners, pharmacists, and specialist nurses, this completely revised and updated third edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. For each drug or drug class, the book lists its classification,mode of action, formulations, dosages, suggested regimens, contraindications, important drug interactions, adverse effects, patient information, and more. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs. FROM REVIEWS OF PREVIOUS EDITIONS "This updated edition includes new arrivals... Quite simply, it is indispensable! I have it with me in every clinic and often refer to it in discussions with pharmacists (who have been known to borrow my copy and forget to return it)." Dermatology in Practice "an outstanding resource that helps to alleviate worrying by providing precise guidelines and advice in managing our most infirm patients who require these medications" SkinMed"--

This book helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.

Arvustused

This wonderful reference book is a delight to read.

- Doody's Review

Preface ix
Contributors x
List of Abbreviations
xiv
Chapter 1 Acitretin
1(5)
Peter C.M. van de Kerkhof
Chapter 2 Acne Antibiotics
6(7)
Alexander Nast
Ricardo N. Werner
Natalie R. Attard
Chapter 3 Alitretinoin
13(6)
N. Farah Mahmood
Graham A. Johnston
Chapter 4 Antiandrogens
19(9)
Shirin Zaheri
Iaisha All
Chapter 5 Antibiotics Commonly Used for Skin Infections
28(14)
Hui Min Liew
Victoria J. Hogarth
Roderick J. Hay
Chapter 6 Antifungals
42(19)
Rachael Morris-Jones
Chapter 7 Antimalarials
61(6)
Thomas Tull
Mark Goodfield
Chapter 8 Antivirals for Herpesviruses
67(7)
Hannah Cookson
Chapter 9 Apremilast
74(4)
Gayathri K. Perera
Chapter 10 Azathioprine
78(6)
Sarah H. Wakelin
Simon Meggitt
Chapter 11 Azole Antihelminths
84(4)
Mahreen Ameen
Chapter 12 Bexarotene
88(5)
Julia J. Scarisbrick
Chapter 13 Cyclosporin
93(6)
Murtaza Khan
John Berth-Jones
Chapter 14 Colchicine
99(5)
Esther A. Hullah
Michael P. Escudier
Chapter 15 Corticosteroids
104(8)
Clive B. Archer
Chapter 16 Cyclophosphamide
112(8)
Matthew Scorer
Olga Golberg
Karen Harman
Chapter 17 Dapsone
120(6)
Charles Archer
Antonia Lloyd-Lavery
Chapter 18 Dimethyl Fumarate
126(5)
Oonagh Molloy
Brian Kirby
Chapter 19 Interleukin-4/13 Inhibitors
131(6)
Alison Sears
Andrew Pink
Chapter 20 Interleukin (IL)-12/23 and IL-23 Inhibitors
137(7)
Charles H. Earnshaw
Richard B. Warren
Chapter 21 Interleukin-17 Inhibitors
144(7)
Leena Chularojanamontri
Christopher E.M. Griffiths
Chapter 22 Isotretinoin
151(8)
Alison M. Lay ton
Chapter 23 Ivermectin
159(5)
Jonathan Kentley
L. Claire Fuller
Chapter 24 Intravenous Immunoglobulin
164(6)
Derrick Phillips
Chapter 25 Janus Kinase (JAK) Inhibitors
170(7)
Courtney E. Heron
Lindsay C. Strowd
Steven R. Feldman
Chapter 26 Malignant Melanoma Drug Treatments
177(18)
Charlotte L. Edwards
Louise A. Fearfield
Chapter 27 Methotrexate
195(8)
Richard Woolf
Catherine Smith
Chapter 28 Mycophenolate Mofetil
203(5)
Joey E. Lai-Cheong
Jane Setterfield
Chapter 29 Omalizumab
208(4)
Chris Rutkowski
Annette Wagner
Clive Grattan
Chapter 30 Potassium Iodide
212(3)
Genevieve Osborne
Chapter 31 Propranolol
215(5)
Susannah Baron
Chapter 32 Psoralens
220(8)
Hiva Fassihi
Chapter 33 Rituximab
228(5)
Richard W. Groves
Chapter 34 Sulfapyridine and Sulfamethoxypyridazine
233(6)
Ellie Rashidghamat
Chapter 35 Thalidomide
239(6)
Elaine Agius
Robert P.E. Sarkany
Chapter 36 Tumour Necrosis Factor Antagonists
245(8)
Leena Chularojanamontri
Christopher E.M. Griffiths
Chapter 37 Vismodegib
253(4)
Faisal R. Ali
John T. Lear
Chapter 38 Systemic Therapy in Children and Young People
257(9)
Susannah Baron
Chapter 39 Systemic Therapy and Kidney Disease
266(4)
Phil Mason
Chapter 40 Systemic Therapy and Liver Disease
270(9)
Maria Bashyam
Shahid A. Khan
Chapter 41 Systemic Therapy in Older People
279(5)
Sarita Singh
Rosanna Fox
Manuraj Singh
Index 284
Edited by

Sarah H. Wakelin, BSc, MB, BS, FRCP, Consultant Dermatologist and Honorary Seniro Lecturer, Imperial College Healthcare NHS Trust, London, UK

Howard I. Maibach, MD, Professor of Dermatology, Department of Dermatology, University of California, San Francisco, USA

Clive B. Archer, BSc, MBBS, MSc Med Ed, MD, PhD (Lond), FRCP, Consultant Dermatologist, St Johns Institute of Dermatology, Guys and St. Thomas Hospitals NHS Foundation Trust, Honorary Professor of Dermatology and Immunopharmacology (UCLan) and Honorary Senior Lecturer (KCL), London, UK